PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and excipients for pharmaceutical and personal care companies worldwide. Its business includes research, product and process development, regulatory approvals, and pilot-scale and plant-scale production. It adds value to its clients' intellectual property through constant innovation in manufacturing techniques for chemical intermediates, active ingredients and excipients throughout the product life cycle. PMC Isochem's facilities are located within 60 miles of Paris and are all US FDA-audited plants.